PPIA and chronic obstructive pulmonary disease: Although our results are predominantly consistent with previous studies, we note that despite reports of enhanced circulating levels of resistin and cyclophilin A in patients with COPD versus healthy control subjects (44, 45), we did not detect such an increase in our COPD cohort.